Leveraging Technology to Diagnose Alzheimer's Disease: A Systematic Review and Meta-Analysis

被引:0
|
作者
Kruse, Clemens Scott [1 ]
Mileski, Michael E. [1 ]
Wilkinson, Reagan [1 ]
Hock, Britney [1 ]
Samson, Roger [1 ]
Castillo, Taylor [1 ]
机构
[1] Texas State Univ, Sch Hlth Adm, San Marcos, TX 78666 USA
关键词
health information technology; Alzheimer's disease; dementia; MILD COGNITIVE IMPAIRMENT; TAU; ASSOCIATION;
D O I
10.3390/healthcare11233013
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
Background: About 50 million people worldwide suffered from dementia in 2018-two-thirds of those with Alzheimer's disease (AD). By 2050, this number is expected to rise to 152 million-which is slightly larger than the country of Russia. About 90% of these people are over the age of 65, but early-onset dementia can occur at younger ages. Early detection is imperative to expedient treatment, which can improve outcomes over the span of diagnosis. Objectives: To conduct a meta-analysis of similar studies along with a systematic literature review to hasten the development of clinical practice guidelines to assist clinicians in the diagnosis of AD. We analyzed data points in each article published over the last 10 years to meet this objective: cost, efficiency, accuracy, acceptability (by physician and patient), patient satisfaction, and barriers to adoption. Methods: Four research databases were queried (PubMed, CINAHL Ultimate, Web of Science, and ScienceDirect). The review was conducted in accordance with a published protocol, the Kruse Protocol, and reported in accordance with PRISMA (2020). Results: Ten interventions were identified to help diagnose AD among older patients, and some involved a combination of methods (such as MRI and PET). The average sample size was 320.32 (SD = 437.51). These 10 interventions were identified as accurate, non-invasive, non-stressful, inexpensive, convenient, and rapid. Only one intervention was identified as statistically ineffective, and this same intervention was used effectively in other studies. The barriers identified were cost, training, expense of travel, and required physical presence of patient. The weighted average sensitivity was 85.16%, specificity was 88.53, and the weighted average effect size was 0.7339 (medium). Conclusion: Innovation can accurately diagnose AD, but not all methods are successful. Providers must ensure they have the proper training and familiarity with these interventions to ensure accuracy in diagnosis. While the physical presence of the patient is often required, many interventions are non-invasive, non-stressful, and relatively inexpensive.
引用
收藏
页数:29
相关论文
共 50 条
  • [31] Differential expression of MicroRNAs in Alzheimer's disease: a systematic review and meta-analysis
    Yoon, Sojung
    Kim, Sung Eun
    Ko, Younhee
    Jeong, Gwang Hun
    Lee, Keum Hwa
    Lee, Jinhee
    Solmi, Marco
    Jacob, Louis
    Smith, Lee
    Stickley, Andrew
    Carvalho, Andre F.
    Dragioti, Elena
    Kronbichler, Andreas
    Koyanagi, Ai
    Hong, Sung Hwi
    Thompson, Trevor
    Oh, Hans
    de Pablo, Gonzalo Salazar
    Radua, Joaquim
    Shin, Jae Il
    Fusar-Poli, Paolo
    [J]. MOLECULAR PSYCHIATRY, 2022, 27 (05) : 2405 - 2413
  • [32] Magnetic Resonance Spectroscopy in Alzheimer's Disease: Systematic Review and Meta-Analysis
    Wang, Hui
    Tan, Lan
    Wang, Hui-Fu
    Liu, Ying
    Yin, Rui-Hua
    Wang, Wen-Ying
    Chang, Xiao-Long
    Jiang, Teng
    Yu, Jin-Tai
    [J]. JOURNAL OF ALZHEIMERS DISEASE, 2015, 46 (04) : 1049 - 1070
  • [33] Effectiveness of Acupuncture for Alzheimer’s Disease: An Updated Systematic Review and Meta-analysis
    Qi Huang
    Dan Luo
    Li Chen
    Feng-xia Liang
    Rui Chen
    [J]. Current Medical Science, 2019, 39 : 500 - 511
  • [34] Cortisol hypersecretion and the risk of Alzheimer's disease: A systematic review and meta-analysis
    Zheng, Bang
    Tal, Roy
    Yang, Zhirong
    Middleton, Lefkos
    Udeh-Momoh, Chinedu
    [J]. AGEING RESEARCH REVIEWS, 2020, 64
  • [35] Cerebrospinal fluid orexin in Alzheimer's disease: a systematic review and meta-analysis
    Treu, Spencer P.
    Plante, David T.
    [J]. SLEEP MEDICINE, 2021, 85 : 230 - 238
  • [36] Intravenous Immunoglobulin for Patients With Alzheimer's Disease: A Systematic Review and Meta-Analysis
    Manolopoulos, Apostolos
    Andreadis, Panagiotis
    Malandris, Konstantinos
    Avgerinos, Ioannis
    Karagiannis, Thomas
    Kapogiannis, Dimitrios
    Tsolaki, Magda
    Tsapas, Apostolos
    Bekiari, Eleni
    [J]. AMERICAN JOURNAL OF ALZHEIMERS DISEASE AND OTHER DEMENTIAS, 2019, 34 (05): : 281 - 289
  • [37] GFAP as a Potential Biomarker for Alzheimer's Disease: A Systematic Review and Meta-Analysis
    Kim, Ka Young
    Shin, Ki Young
    Chang, Keun-A
    [J]. CELLS, 2023, 12 (09)
  • [38] Pharmacological Therapy for Apathy in Alzheimer's Disease: A Systematic Review and Meta-Analysis
    Sepehry, Amir A.
    Sarai, Michael
    Hsiung, Ging-Yuek R.
    [J]. CANADIAN JOURNAL OF NEUROLOGICAL SCIENCES, 2017, 44 (03) : 267 - 275
  • [39] Pesticide exposure and risk of Alzheimer’s disease: a systematic review and meta-analysis
    Dandan Yan
    Yunjian Zhang
    Liegang Liu
    Hong Yan
    [J]. Scientific Reports, 6
  • [40] Sleep in Alzheimer’s disease: a systematic review and meta-analysis of polysomnographic findings
    Ye Zhang
    Rong Ren
    Linghui Yang
    Haipeng Zhang
    Yuan Shi
    Hamid R. Okhravi
    Michael V. Vitiello
    Larry D. Sanford
    Xiangdong Tang
    [J]. Translational Psychiatry, 12